1. Home
  2. UPST vs SUPN Comparison

UPST vs SUPN Comparison

Compare UPST & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upstart Holdings Inc.

UPST

Upstart Holdings Inc.

HOLD

Current Price

$29.40

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.15

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPST
SUPN
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
UPST
SUPN
Price
$29.40
$48.15
Analyst Decision
Buy
Strong Buy
Analyst Count
16
5
Target Price
$45.84
$61.60
AVG Volume (30 Days)
4.1M
916.2K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
131.25
N/A
EPS
N/A
N/A
Revenue
$1,043,857,000.00
$392,755,000.00
Revenue This Year
$34.45
$22.70
Revenue Next Year
$32.64
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
63.99
N/A
52 Week Low
$23.97
$32.21
52 Week High
$85.31
$59.68

Technical Indicators

Market Signals
Indicator
UPST
SUPN
Relative Strength Index (RSI) 39.82 54.04
Support Level $25.18 $47.48
Resistance Level $30.67 $52.24
Average True Range (ATR) 1.96 1.58
MACD -0.49 0.10
Stochastic Oscillator 9.21 38.42

Price Performance

Historical Comparison
UPST
SUPN

About UPST Upstart Holdings Inc.

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The company support development of different lending product offerings, which are grouped into three operating segments - Personal Lending (unsecured personal loans and small dollar loans), Auto Lending (auto refinance, auto retail loans, and auto secured personal loans), and Other (HELOCs and other).

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: